Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 510 results for "cadila healthcare"

Cadila launches cheaper copy of top-selling drug in India
Business Today India

India Launches First Biosimilar for World's Top-selling Drug

India-based Cadila Healthcare has launched the first biosimilar version of the world's top-selling drug anti-inflammatory medicine adalimumab -- for a fifth of its U.S. price. The branded version of adalimumab is sold under the name Humira by ... Pharmaceutical Manufacturing Magazine, 1 week ago
Humira biosimilar launched in India Seeking Alpha, 1 week ago

14 images for cadila healthcare

India TV, 1 week ago
Money Today, 1 week ago
Nasdaq, 6 days ago
Sify, 1 week ago
Business Standard, 1 week ago
Business Standard, 1 week ago, 1 month ago, 1 month ago
Forbes India, 1 month ago
Financial Express, 2 months ago
Business Standard

Cadila Healthcare: Strong US, India growth prospects

Launch of innovative products heartening; product portfolio in US, India to drive near-term growth Ujjval Jauhari | New Delhi December 9, 2014 Last Updated at 21:35 IST Cadila Healthcare continues working on drug innovations. It announced the launch of its ...
 Business Standard1 week ago Cadila Healthcare rises on launching world's first bio-similar of Adalimumab  Arihant Capital1 week ago Zydus launches world's first biosimilar of Adalimumab  Moneycontrol.com1 week ago Zydus Cadila launches bio-similar of Adalimumab  Hindu Business Line1 week ago


Cadila Healthcare Ltd of Ahmedabad, is recalling 15,144 bottles of its anti hypertension drug Amlodipine Besylate tablets in the US due to discoloration. According to the US Food and Drug Administration, brown spots were noted ...
 4 Traders4 days ago Nod by international regulators key for Cadila: Dandekar  Moneycontrol.com1 week ago CADILA HEALTHCARE : Recalls hypertension drug in us  4 Traders1 week ago Cadila Healthcare slips on buzz of recalling bottles of hypertension drug in US  Capital Market1 week ago

Cadila looks beyond generic drugs

The 62-year-old Cadila Healthcare has its sights set on new horizons: in a first, the company recently introduced its own in-house formulation. Till this launch, the company has been specialising in generic drugs. So, what was significant about ...
 Hindu Business Line1 week ago CADILA HEALTHCARE : Looks beyond generic drugs  4 Traders1 week ago CADILA HEALTHCARE : Bt500 rankings: india's most valuable top-500 companies - cadila healthcare limited  4 Traders1 month ago
Business Standard India

Govt caps prices of 52 more 'essential' drugs

Email this Print Related to : Lupin Ltd,Cadila Healthcare Ltd Lupin Ltd BSE 12 Dec 14 | 02:16 PM 1449.65 13 (0.9%) NSE 12 Dec 14 | 02:04 PM 1459.35 22.3 (1.55%) The government has capped the prices of 52 more drugs, including ...
 Business Standard India1 week ago India extends price caps to 52 more essential drugs  Yahoo! Finance1 week ago UPDATE 2-India extends price caps to 52 more essential drugs  Reuters1 week ago Cap on prices of over 52 drugs  Asian Age1 week ago

Cadila Healthcare Ltd clarifies on recall of benzonatate capsules

Posted On: 2014-12-17 20:30:20 The Exchange had sought clarification from Cadila Healthcare Ltd with respect to news appearing in DNA on December 17, 2014 titled "Cadila's US Arm recalls 63,648 bottles of benzonatate capsules."Cadila Healthcare ...
 Equity Bulls4 days ago Cadila Healthcare unveils cheaper copy of top drug  Asian Age1 week ago

F-6EF - Cadila Healthcare Ltd/ADR (0001627912) (Subject)

Document Format Files Seq Description Document Type Size 1 e613081_f6ef-cadila.htm F-6EF 89119 2 e613081_ex99-a.htm EX-99.(A) 98549 3 e613081_ex99-d.htm EX-99.(D) 8185 4 e613081_ex99-e.htm EX-99.(E) 8086 Complete submission text file ...
 SEC Filings2 days ago

Abbott Healthcare, GlaxoSmithKline hit most by fresh control on drug prices

Pharma market worth Rs 123 crore under price control as NPPA caps prices of 52 drugs The move by National Pharmaceutical Pricing Authority (NPPA) to cap prices of 52 formulations may not hit drug makers much as the total market size of ...
 DNA India1 week ago Wockhardt : Fresh price control to hit Abbott, GSK  4 Traders6 days ago

Dr Jyotsna Suri takes over as President of FICCI

Dr Jyotsna Suri, Chairman & Managing Director, Bharat Hotels (Lalit Suri Hospitality), has been appointed as President of Federation of Indian Chambers of Commerce and Industry (FICCI). The announcement of the appointment was made at the conclusion ...
 Hospitality Biz India3 hours ago Jyotsna Suri takes over as Ficci president  The Statesman14 hours ago

Shares of Torrent, Adani group companies surge

Gandhinagar: The shares of companies of Torrent and Adani groups surged on the stock exchanges on Thursday. The stocks of Torrent group companies were up by as much as 18.6%, while those of Adani group were up by up to 6%. Shares of power ...
 4 Traders1 day ago Market may surge on firm global stocks  Business Standard India4 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - cadila healthcare
Get updated on latest news & your favorite topics right in your inbox!
More     Less